Replies to post #111736 on Anavex Life Sciences Corp (AVXL)

[riaguy]

Hope is not a valid investment strategy. AXON puts out a meaningless PR today regarding pre-clinical possibilities and goes up 4% while Missling sits on 18 month data.

[Luckykr]

Amazing what a PR can do for any stock !!! AXON is now currently up 5% !

Axovant is evaluating intepirdine in MINDSET, a global, multi-center, double-blind, placebo-controlled Phase 3 study in subjects with mild to moderate Alzheimer's disease who are on stable background donepezil therapy, and expects to report topline results from this study in late September 2017.